Stock analysts at Mizuho started coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the biopharmaceutical company’s stock. Several other research firms have also commented on VSTM. HC Wainwright reiterated a “buy” rating and issued a […]
Verastem (NASDAQ:VSTM – Get Rating) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.01, MarketWatch Earnings reports. Verastem had a negative return on equity of 74.56% and a negative net margin of 3,468.09%. NASDAQ VSTM traded up $0.04 on Wednesday, […]
StockNews.com downgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a hold rating to a sell rating in a research report released on Monday. Separately, Truist Financial initiated coverage on Verastem in a report on Wednesday, March 9th. They set a buy rating and a $6.00 price objective for the company. One investment analyst has […]
Goldman Sachs Group Inc Sells 167,457 Shares of Verastem, Inc (NASDAQ:VSTM) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.